鼻腔分泌物中生物标志物在慢性鼻窦炎内在型诊断和临床应用中的研究进展

靳晶; 许昱

doi:10.13201/j.issn.2096-7993.2022.11.017

鼻腔分泌物中生物标志物在慢性鼻窦炎内在型诊断和临床应用中的研究进展

靳晶¹,
许昱^1, ,

- 武汉大学人民医院耳鼻咽喉头颈外科(武汉，430060)

详细信息

通讯作者: 许昱，E-mail：yux@whu.edu.cn

中图分类号: R765.4

收稿日期: 2022-02-26

刊出日期: 2022-11-03

Research progress of biomarkers in nasal secretions in endotypes diagnosis and clinical application of chronic rhinosinusitis

JIN Jing¹,
XU Yu^1, ,

- Department of Otolaryngology Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, 430060, China

More Information

Corresponding author: XU Yu, E-mail: yux@whu.edu.cn

Received Date: 26 February 2022

Publish Date: 03 November 2022

摘要

摘要: 随着慢性鼻窦炎(CRS)内在型及鼻腔分泌物标志物的相关研究不断取得进展，基于鼻腔分泌物对CRS内在型的研究愈加丰富。本文总结了CRS的内在型分类、鼻腔分泌物的采集方法以及与CRS内在型相关的鼻腔分泌物标志物，以期为以鼻腔分泌物标志物为基础建立相应的CRS内在型分型提供参考。
- 鼻窦炎 /
- 生物标志 /
- 内在型 /
- 鼻腔分泌物
Abstract: With the development of studies on the endotypes of chronic rhinosinusitis (CRS) and the biomarkers of nasal secretions, the studies of CRS endotypes based on nasal secretion have become more abundant. This paper summarizes the endotypes classification of CRS, the collection methods of nasal secretion and the nasal secretion biomarkers related to the endotypes of CRS, in order to provide a reference for establishing the corresponding endotypes of CRS based on the nasal secretion biomarkers.
- sinusitis /
- biomarker /
- endotype /
- nasal secretion

HTML全文

参考文献(37)

[1]	Hopkins C. Chronic Rhinosinusitis with Nasal Polyps[J]. N Engl J Med, 2019, 381(1): 55-63. doi: 10.1056/NEJMcp1800215
[2]	Fujieda S, Imoto Y, Kato Y, et al. Eosinophilic chronic rhinosinusitis[J]. Allergol Int, 2019, 68(4): 403-412. doi: 10.1016/j.alit.2019.07.002
[3]	Cao PP, Li HB, Wang BF, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese[J]. J Allergy Clin Immunol, 2009, 124(3): 478-484. e1-2. doi: 10.1016/j.jaci.2009.05.017
[4]	Tan BK, Klingler AI, Poposki JA, et al. Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois[J]. J Allergy Clin Immunol, 2017, 139(2): 699-703. e7. doi: 10.1016/j.jaci.2016.06.063
[5]	Stevens WW, Peters AT, Tan BK, et al. Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis[J]. J Allergy Clin Immunol Pract, 2019, 7(8): 2812-2820. e3. doi: 10.1016/j.jaip.2019.05.009
[6]	Tomassen P, Vandeplas G, Van Zele T, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers[J]. J Allergy Clin Immunol, 2016, 137(5): 1449-1456. e4. doi: 10.1016/j.jaci.2015.12.1324
[7]	Turner JH, Chandra RK, Li P, et al. Identification of clinically relevant chronic rhinosinusitis endotypes using cluster analysis of mucus cytokines[J]. J Allergy Clin Immunol, 2018, 141(5): 1895-1897. e7. doi: 10.1016/j.jaci.2018.02.002
[8]	Peric A, Vojvodic D, Radulovic V et al. Correlation between cytokine levels in nasal fluid and eosinophil counts in nasal polyp tissue in asthmatic and non-asthmatic patients[J]. Allergol Immunopathol(Madr), 2011, 39(3): 133-139. doi: 10.1016/j.aller.2010.05.001
[9]	Klingler AI, Stevens WW, Tan BK et al. Mechanisms and biomarkers of inflammatory endotypes in chronic rhinosinusitis without nasal polyps[J]. J Allergy Clin Immunol, 2021, 147(4): 1306-1317. doi: 10.1016/j.jaci.2020.11.037
[10]	Millqvist E, Ternesten-Hasséus E, Ståhl A, et al. Changes in levels of nerve growth factor in nasal secretions after capsaicin inhalation in patients with airway symptoms from scents and chemicals[J]. Environ Health Perspect, 2005, 113(7): 849-852. doi: 10.1289/ehp.7657
[11]	Watelet JB, Gevaert P, Holtappels G, et al. Collection of nasal secretions for immunological analysis[J]. Eur Arch Otorhinolaryngol, 2004, 261(5): 242-246. doi: 10.1007/s00405-003-0691-y
[12]	Kao SS, Ramezanpour M, Bassiouni A et al. Barrier disruptive effects of mucus isolated from chronic rhinosinusitis patients[J]. Allergy, 2020, 75(1): 200-203. doi: 10.1111/all.13964
[13]	Turner JH, Li P, Chandra RK. Mucus T helper 2 biomarkers predict chronic rhinosinusitis disease severity and prior surgical intervention[J]. Int Forum Allergy Rhinol, 2018, 8(10): 1175-1183. doi: 10.1002/alr.22160
[14]	Soler ZM, Schlosser RJ, Mulligan JK et al. Olfactory cleft mucus proteome in chronic rhinosinusitis: a case-control pilot study[J]. Int Forum Allergy Rhinol, 2021, 11(8): 1162-1176. doi: 10.1002/alr.22743
[15]	Oyer SL, Mulligan JK, Psaltis AJ et al. Cytokine correlation between sinus tissue and nasal secretions among chronic rhinosinusitis and controls[J]. Laryngoscope, 2013, 123(12): E72-E78. doi: 10.1002/lary.24305
[16]	Soler ZM, Schlosser RJ, Bodner TE et al. Endotyping chronic rhinosinusitis based on olfactory cleft mucus biomarkers[J]. J Allergy Clin Immunol, 2021, 147(5): 1732-1741. doi: 10.1016/j.jaci.2021.01.021
[17]	Schlosser RJ, Mulligan JK, Hyer JM et al. Mucous Cytokine Levels in Chronic Rhinosinusitis-Associated Olfactory Loss[J]. JAMA Otolaryngol Head Neck Surg, 2016, 142(8): 731-737. doi: 10.1001/jamaoto.2016.0927
[18]	Stoop AE, van der Heijden HA, Biewenga J, et al. Eosinophils in nasal polyps and nasal mucosa: an immunohistochemical study[J]. J Allergy Clin Immunol, 1993, 91(2): 616-622. doi: 10.1016/0091-6749(93)90267-J
[19]	Rothenberg ME, Hogan SP. The eosinophil[J]. Annu Rev Immunol, 2006, 24: 147-174. doi: 10.1146/annurev.immunol.24.021605.090720
[20]	Schmid C, Habermann W, Braun H et al. Released intranasal eosinophilic major basic protein as a diagnostic marker for polypoid chronic rhinosinusitis[J]. Otolaryngol Head Neck Surg, 2010, 143(3): 386-391. doi: 10.1016/j.otohns.2010.05.017
[21]	Wu D, Yan B, Wang Y et al. Charcot-Leyden crystal concentration in nasal secretions predicts clinical response to glucocorticoids in patients with chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2019, 144(1): 345-348. doi: 10.1016/j.jaci.2019.03.029
[22]	Wu D, Yan B, Wang Y et al. Predictive Significance of Charcot-Leyden Crystal Protein in Nasal Secretions in Recurrent Chronic Rhinosinusitis with Nasal Polyps[J]. Int Arch Allergy Immunol, 2021, 182(1): 65-75. doi: 10.1159/000510120
[23]	Imoto Y, Tokunaga T, Matsumoto Y et al. Cystatin SN upregulation in patients with seasonal allergic rhinitis[J]. PLoS One, 2013, 8(8): e67057. doi: 10.1371/journal.pone.0067057
[24]	Wu D, Yan B, Wang Y et al. Prognostic and pharmacologic value of cystatin SN for chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2021, 148(2): 450-460. doi: 10.1016/j.jaci.2021.01.036
[25]	Chowdhury NI, Li P, Chandra RK et al. Baseline mucus cytokines predict 22-item Sino-Nasal Outcome Test results after endoscopic sinus surgery[J]. Int Forum Allergy Rhinol, 2020, 10(1): 15-22. doi: 10.1002/alr.22449
[26]	Morse JC, Shilts MH, Ely KA et al. Patterns of olfactory dysfunction in chronic rhinosinusitis identified by hierarchical cluster analysis and machine learning algorithms[J]. Int Forum Allergy Rhinol, 2019, 9(3): 255-264. doi: 10.1002/alr.22249
[27]	Chapurin N, Li P, Chandra RK, et al. Elevated mucus interleukin-17A levels are associated with increased prior sinus surgery for chronic rhinosinusitis[J]. Int Forum Allergy Rhinol, 2021, 11(2): 120-127. doi: 10.1002/alr.22652
[28]	Otto BA, Wenzel SE. The role of cytokines in chronic rhinosinusitis with nasal polyps[J]. Curr Opin Otolaryngol Head Neck Surg, 2008, 16(3): 270-274. doi: 10.1097/MOO.0b013e3282fb2885
[29]	Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators[J]. Allergy, 2006, 61(11): 1280-1289. doi: 10.1111/j.1398-9995.2006.01225.x
[30]	Rockstrom MD, Chen L, Taishi P, et al. Tumor necrosis factor alpha in sleep regulation[J]. Sleep Med Rev, 2018, 40: 69-78. doi: 10.1016/j.smrv.2017.10.005
[31]	Kao SS, Bassiouni A, Ramezanpour M et al. Proteomic analysis of nasal mucus samples of healthy patients and patients with chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2021, 147(1): 168-178. doi: 10.1016/j.jaci.2020.06.037
[32]	Tieu DD, Peters AT, Carter RG et al. Evidence for diminished levels of epithelial psoriasin and calprotectin in chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2010, 125(3): 667-675. doi: 10.1016/j.jaci.2009.11.045
[33]	Adams M. Tissue factor pathway inhibitor: new insights into an old inhibitor[J]. Semin Thromb Hemost, 2012, 38(2): 129-134. doi: 10.1055/s-0032-1301410
[34]	Shimizu S, Ogawa T, Takezawa K et al. Tissue factor and tissue factor pathway inhibitor in nasal mucosa and nasal secretions of chronic rhinosinusitis with nasal polyp[J]. Am J Rhinol Allergy, 2015, 29(4): 235-242. doi: 10.2500/ajra.2015.29.4183
[35]	Cha S, Seo EH, Lee SH et al. MicroRNA Expression in Extracellular Vesicles from Nasal Lavage Fluid in Chronic Rhinosinusitis[J]. Biomedicines, 2021, 9(5).
[36]	Du K, Huang Z, Si W, et al. Dynamic Change of T-Helper Cell Cytokines in Nasal Secretions and Serum after Endoscopic Sinus Surgery in Chronic Rhinosinusitis with Nasal Polyps[J]. ORL J Otorhinolaryngol Relat Spec, 2020, 82(2): 74-85. doi: 10.1159/000504580
[37]	Yancey KL, Li P, Huang LC, et al. Longitudinal stability of chronic rhinosinusitis endotypes[J]. Clin Exp Allergy, 2019, 49(12): 1637-1640. doi: 10.1111/cea.13502